News & Articles

25

Articles Filter

Explore by Field
Browse by Techniques
Explore by Company
Explore by Content

Search



Expert Insights

A structured step toward modernizing preclinical drug development

In this guest editorial, Dr. Kent Grindstaff from BIoIVT discusses how the FDA’s draft guidance on New Approach Methodologies (NAMs) signifies a structured advancement in integrating innovative, non-animal methods into preclinical drug development